Enteric-Coated Mycophenolate Sodium: One-Way Conversion From Mycophenolate Mofetil and De Novo Use in Stable Liver Transplant Recipients

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1290-1292

  Nure, E ^a   Magalini, S C ^a   Frongillo, F ^a   Barbarino, R ^a   Pepe, G ^a   Avolio, A W ^a   Agnes, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; EVEROLIMUS; INTERFERON; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTON PUMP INHIBITOR; TACROLIMUS; DRUG DOSAGE FORM; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BONE MARROW DEPRESSION; CHOLESTASIS; CLINICAL ARTICLE; CREATININE CLEARANCE; DIARRHEA; DRUG BLOOD LEVEL; DRUG COATING; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; HEARTBURN; HEPATITIS C; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LIVER FIBROSIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STIPSIS; ANALOGS AND DERIVATIVES; DRUG DOSAGE FORM; DRUG EFFECTS; GASTROINTESTINAL TRACT;

DOSAGE FORMS; GASTROINTESTINAL TRACT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MYCOPHENOLIC ACID;

EID: 65549105859     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.041     Document Type: Article

References (7)

1. De Winter B.C.M., van Gelder T., Glander P., et al. Population pharmacokinetics of mycophenolic acid. Clin Pharmacokinet 47 (2008) 827
2. Arns W., Breuer S., Choudhury S., et al. Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mophetil. Clin Transplant 19 (2005) 199
3. Perry T.W., Christinas U., Trotter J.F., et al. Pharmacokinetics of enteric-coated mycophenolate sodium in stable liver transplant recipients. Clin Transplant 21 (2007) 413
4. Schmidt H., and Brockman J. MMF to EC-MPS conversion: what makes the difference?. Liver Transpl 13 (2007) 773
5. Doria C., et al. Use of enteric coated mycophenolate sodium as part of an immunosuppressive regimen in liver transplant patients suffering from intestinal intolerance and/or poor quality of life related to the use of mycophenolate mophetil. Am J Transplant 2 Suppl (2008) 543
6. Dumortier J., Gagnieu M.-C., Salandre J., et al. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: a pilot study. Liver Transpl 12 (2006) 1342
7. Cantisani G.P., Zanotelli M.L., Gleisner A.L., et al. Enteric-coated mycophenolate sodium experience in liver transplant patients. Transplant Proc 38 (2006) 932